GL1X · GenesisL1 explorer

Research workbench

Human tankyrase 1 with small molecule inhibitor

Analyse Human tankyrase 1 with small molecule inhibitor in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4W6E
Type
protein
Length
210 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Tankyrase-1
EC
2.4.2.30
UniProt
O95271
Ligands
3J5, ZN
Pockets
1 · best druggability 0.67

Structure

x-ray diffraction · 1 distinct chain · 24% helix, 29% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATankyrase-1 (EC 2.4.2.30)protein21024% helix, 29% strandO95271

Ligands and binding sites

  • 3J5 · 2-(4-{6-[(3S)-3,4-dimethylpiperazin-1-yl]-4-methylpyridin-3-yl}phenyl)-8-(hydroxymethyl)quinazolin-4(3H)-one · ligand · chains A
  • ZN · Zinc ion · metal · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12870.670.82403J5

Compared structures

  • 4W6E · Human Tankyrase 1 with small molecule inhibitor · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.